Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Junji Ueda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6189-0762; OpenAlex author ID A5076611355, A5103248629. Sources: OpenAlex.

Their work

Papers
16
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 2 papers · 2014: 6 papers · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 16

  1. ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer. Co-author DOI 10.3389/fonc.2026.1902440↗
  2. Cancer‑associated fibroblast‑derived extracellular vesicles promote pancreatic cancer progression via the RAP1B/ANLN axis. Co-author DOI 10.3892/or.2026.9182↗
  3. Pancreatectomy with Celiac Axis Resection and Reconstruction for Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers16234115↗
  4. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000258↗
  5. Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study. Co-author DOI 10.1097/mpa.0000000000000393↗
  6. Role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-014-0845-0↗
  7. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice. Co-author DOI 10.1016/j.ajpath.2013.11.014↗
  8. Follicular pancreatitis, report of a case clinically mimicking pancreatic cancer and literature review. Co-author DOI 10.1016/j.prp.2013.09.005↗
  9. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary m… Co-author DOI 10.1016/j.surg.2013.06.059↗
  10. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Co-author DOI 10.1038/onc.2013.392↗
  11. Hepaticocholecystojejunostomy as effective palliative biliary bypass for unresectable pancreatic cancer. Co-author PMID 24895820↗
  12. Surgery for chronic pancreatitis decreases the risk for pancreatic cancer: a multicenter retrospective analysis. Co-author DOI 10.1016/j.surg.2012.08.005↗
  13. Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal pa… Co-author DOI 10.6092/1590-8577/1494↗
  14. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer. Co-author DOI 10.3892/ijo.2011.1280↗
  15. Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. Co-author DOI 10.1111/j.1349-7006.2011.01936.x↗
  16. MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Co-author DOI 10.1245/s10434-011-1602-x↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akira Matsushita · 2 shared papers, 2026 · strength 0.50
  2. Hiroshi Yoshida · 2 shared papers, 2024–2026 · strength 0.42
  3. Masao Tanaka · 10 shared papers, 2011–2015 · strength 0.37
  4. Takao Ohtsuka · 9 shared papers, 2011–2015 · strength 0.34
  5. Ayumi Kashiro · 1 shared paper, 2026 · strength 0.27
  6. Kazufumi Honda · 1 shared paper, 2026 · strength 0.27
  7. Ryuji Ohashi · 1 shared paper, 2026 · strength 0.23
  8. Kousuke Ishino · 1 shared paper, 2026 · strength 0.23
  9. Daigo Yoshimori · 1 shared paper, 2026 · strength 0.23
  10. Atsushi Masamune · 1 shared paper, 2026 · strength 0.23
  11. Masato Yoshioka · 1 shared paper, 2024 · strength 0.19
  12. Satoshi Mizutani · 1 shared paper, 2024 · strength 0.19
  13. Yoshinao Oda · 5 shared papers, 2013–2015 · strength 0.18
  14. Koji Tamura · 5 shared papers, 2013–2015 · strength 0.18
  15. Noboru Ideno · 5 shared papers, 2013–2015 · strength 0.18
  16. Zenya Naito · 3 shared papers, 2012–2014 · strength 0.13
  17. Toshiyuki Ishiwata · 3 shared papers, 2012–2014 · strength 0.13
  18. Hiroshi Kono · 3 shared papers, 2013–2014 · strength 0.10
  19. Tadashi Kayashima · 3 shared papers, 2011–2014 · strength 0.10
  20. Murray Korc · 2 shared papers, 2014 · strength 0.10
  21. Kenoki Ohuchida · 3 shared papers, 2011–2015 · strength 0.09
  22. Yasuhisa Mori · 2 shared papers, 2014 · strength 0.08
  23. Eiji Uchida · 2 shared papers, 2012–2014 · strength 0.08
  24. Taketo Matsunaga · 2 shared papers, 2015 · strength 0.08
  25. Yusuke Watanabe · 2 shared papers, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.